Nicholson, C. David — SEC insider filings

SEC reporting owner CIK 1636168. 10 insider filings on record with FilingPulse; latest filed 2026-09-04.

Transaction summary — filings shown

Covers all 10 filings on record, filed 2020-08-14 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Actinium Pharmaceuticals, Inc. (ATNM)Director6——14
Adverum Biotechnologies, Inc. (ADVM)Director4——6

Insider filings — Nicholson, C. David

FiledFormIssuerReported transactionsSource
2026-09-044Actinium Pharmaceuticals, Inc. (ATNM)Grant/award (A): 62,800 @ $0 · Grant/award (A): 94,200 (derivative) @ $0EDGAR
2025-12-104Adverum Biotechnologies, Inc. (ADVM)Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 10,520 (derivative) · Disposition to issuer (D): 10,450 (derivative)EDGAR
2025-06-204Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 10,450 (derivative) @ $0EDGAR
2025-04-024Actinium Pharmaceuticals, Inc. (ATNM)Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 8,333 (derivative) @ $0 · Disposition to issuer (D): 18,351 (derivative) @ $0 · +2 moreEDGAR
2024-06-204Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 10,520 (derivative) @ $0EDGAR
2023-12-294Actinium Pharmaceuticals, Inc. (ATNM)Grant/award (A): 70,311 (derivative) @ $0EDGAR
2023-11-064Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2022-07-014Actinium Pharmaceuticals, Inc. (ATNM)Grant/award (A): 72,156 (derivative) @ $0EDGAR
2021-09-034Actinium Pharmaceuticals, Inc. (ATNM)Grant/award (A): 18,351 (derivative) @ $0EDGAR
2020-08-144Actinium Pharmaceuticals, Inc. (ATNM)Grant/award (A): 8,333 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1636168 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs